tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abeona Therapeutics reports Q2 EPS ($1.71) vs (26c) last year
PremiumThe FlyAbeona Therapeutics reports Q2 EPS ($1.71) vs (26c) last year
2M ago
Abeona Therapeutics expects cash to fund operations for over two years
Premium
The Fly
Abeona Therapeutics expects cash to fund operations for over two years
2M ago
Abeona Therapeutics announces employee inducement grants
Premium
The Fly
Abeona Therapeutics announces employee inducement grants
2M ago
Positive Outlook for Abeona Therapeutics Amid FDA Challenges and Promising ZEVASKYN Launch
PremiumRatingsPositive Outlook for Abeona Therapeutics Amid FDA Challenges and Promising ZEVASKYN Launch
3M ago
Fair Isaac, Aeva, Abeona, Cipher, Verisign: Insider Sales Unveiled!
Premium
Weekend Updates
Fair Isaac, Aeva, Abeona, Cipher, Verisign: Insider Sales Unveiled!
3M ago
Abeona Therapeutics Sells Priority Review Voucher for $155M
Premium
Company Announcements
Abeona Therapeutics Sells Priority Review Voucher for $155M
3M ago
Abeona Therapeutics Advances DEB Treatment with Phase 3b Study
PremiumCompany AnnouncementsAbeona Therapeutics Advances DEB Treatment with Phase 3b Study
3M ago
Abeona Therapeutics announces publication in The Lancet of Phase 3 VITAL study
Premium
The Fly
Abeona Therapeutics announces publication in The Lancet of Phase 3 VITAL study
3M ago
Abeona Therapeutics assumed with an Outperform at Oppenheimer
Premium
The Fly
Abeona Therapeutics assumed with an Outperform at Oppenheimer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100